JPRN-jRCT2072210002已完成3 期
SP2Y-GMF CLINICAL STUDY
Eguchi Shuichiro0 个研究点目标入组 64 人开始时间: 2021年4月2日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
The investigational device was shown to be effective and safe for correcting visual acuity at far, intermediate and near distances and reducing astigmatism in aphakia after cataract operation.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 22age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients with bilateral cataract, aged 22 or more years at the time of consent
- •2) Patients who desire to receive bilateral cataract surgery and implantation
- •3) Patients with planned 2nd eye surgery within the period of 7-30 days after the 1st eye surgery
- •4) Other patients who meet the inclusion crirteria stipulated in the clinical trial protocol
排除标准
- •1) Patients with history of corneal transplant
- •2) Patients with history of refractive surgery
- •3) Patients with history of intraocular surgery
- •4) Patients with glaucoma
- •5) Patients with previous or acute retinal detachment
- •6) Patients with retinal degenerative disorders
- •7) Patients with a plan to have an intraocular surgery other than implantation of the investigational devices during the study period
- •8) Other patients who meet the exclusion crirteria stipulated in the clinical trial protocol
研究者
相似试验
已完成
不适用
Clinical Investigation of the Next Generation Intraocular LensCataractNCT03500198Johnson & Johnson Surgical Vision, Inc.247
进行中（未招募）
不适用
Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy - NDMedDRA version: 8.1Level: LLTClassification code 10012689Term: Diabetic retinopathyDiabetic RetinopathyEUCTR2006-005315-10-ITOSPEDALE SACRO CUORE-DON CALABRIA
撤回
2 期
OSIG-eye Drops Treatment for Dry Eye DiseaseDry EyeNCT04510428University of Illinois at Chicago
已完成
不适用
Investigation on cataract treatment result using multi-focal intraocular lens, AcrivaUDReviol Tri-ED and Tri-ED T 611Age-related cataractJPRN-UMIN000028520Chukyo Eye Clinic20
进行中（未招募）
不适用
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150